Cargando…

Cranial multineuritis associated with anti-GM2 ganglioside antibodies after SARS-CoV-2 infection

Detalles Bibliográficos
Autores principales:	Torres Gómez, Antonio, De la Hera Fernández, Francisco Javier, Callejas Rubio, José Luis
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier España, S.L.U. 2023
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10266496/ https://www.ncbi.nlm.nih.gov/pubmed/37361370 http://dx.doi.org/10.1016/j.medcle.2023.03.008

Ejemplares similares

Multineuritis craneal asociada con anticuerpos antigangliósidos anti-GM2 tras infección por SARS-CoV-2
por: Torres Gómez, Antonio, et al.
Publicado: (2023)

Neurolymphomatosis in non-Hodgkin lymphoma with cranial multineuritis: A case report
por: Haydaroglu Sahin, Handan, et al.
Publicado: (2018)

Selective cranial multineuritis in severe COVID-19 pneumonia: two cases and literature review
por: De Gennaro, R., et al.
Publicado: (2021)

Efficacy and safety of SARS-CoV-2 vaccine in patients with giant cell arteritis()
por: Callejas Rubio, José Luis, et al.
Publicado: (2022)

Clinical Heterogeneity of Anti-GM2-Ganglioside-Antibody Syndrome
por: Kim, Jong Kuk, et al.
Publicado: (2018)

Secondary ganglioside GM2 accumulation in mucopolysaccharidoses
por: Sandhoff, Konrad
Publicado: (2021)

Eficacia y seguridad de la vacuna frente a SARS-CoV-2 en pacientes con arteritis de células gigantes
por: Callejas Rubio, José Luis, et al.
Publicado: (2022)

Pathophysiology of Ganglioside GM1 in Ischemic Stroke: Ganglioside GM1: A Critical Review
por: Zhang, Wenchao, et al.
Publicado: (2019)

Biochemical Correction of GM2 Ganglioside Accumulation in AB-Variant GM2 Gangliosidosis
por: Deschenes, Natalie M., et al.
Publicado: (2023)

Ganglioside GM2: a potential biomarker for cholangiocarcinoma
por: Talabnin, Krajang, et al.
Publicado: (2020)

Identification of possible binding modes of SARS-CoV-2 spike N-terminal domain for ganglioside GM1
por: Das, Tanushree, et al.
Publicado: (2023)

NGcGM3 Ganglioside: A Privileged Target for Cancer Vaccines
por: Fernandez, Luis E., et al.
Publicado: (2010)

Physiopathological function of hematoside (GM3 ganglioside)
por: INOKUCHI, Jin-ichi
Publicado: (2011)

Ganglioside GM1 and the Central Nervous System
por: Guo, Zhongwu
Publicado: (2023)

Anti‐ganglioside GM(2) Monoclonal Antibody‐dependent Killing of Human Lung Cancer Cells by Lymphocytes and Monocytes
por: Hanibuchi, Masaki, et al.
Publicado: (1996)

Ganglioside GM3 Is Antiangiogenic in Malignant Brain Cancer
por: Seyfried, Thomas N., et al.
Publicado: (2010)

GM1 ganglioside-independent intoxication by Cholera toxin
por: Cervin, Jakob, et al.
Publicado: (2018)

Turning the spotlight on the oligosaccharide chain of GM1 ganglioside
por: Chiricozzi, Elena, et al.
Publicado: (2021)

The Key Role of GM1 Ganglioside in Parkinson’s Disease
por: Chowdhury, Suman, et al.
Publicado: (2022)

Effectiveness of corticoid pulses in patients with cytokine storm syndrome induced by SARS-CoV-2 infection()
por: Callejas Rubio, José Luis, et al.
Publicado: (2020)

GM2-GM3 gangliosides ratio is dependent on GRP94 through down-regulation of GM2-AP cofactor in brain metastasis cells
por: Bedia, Carmen, et al.
Publicado: (2019)

Preparation of Ganglioside GM1 by Supercritical CO(2) Extraction and Immobilized Sialidase
por: Ji, Li, et al.
Publicado: (2019)

Multineuritis craneal y mielitis transversa como complicaciones de una meningitis neumocócica
por: Espinosa-Rueda, Judith, et al.
Publicado: (2022)

Sialidase NEU3 action on GM1 ganglioside is neuroprotective in GM1 gangliosidosis
por: Allende, Maria L., et al.
Publicado: (2023)

Disordered testosterone transport in mice lacking the ganglioside GM2/GD2 synthase gene
por: Furukawa, Koichi, et al.
Publicado: (2023)

Elevated ganglioside GM2 activator (GM2A) in human brain tissue reduces neurite integrity and spontaneous neuronal activity
por: Hsieh, Yi-Chen, et al.
Publicado: (2022)

Anti-inflammatory role of GM1 and other gangliosides on microglia
por: Galleguillos, Danny, et al.
Publicado: (2022)

The cytoprotective role of GM1 ganglioside in Huntington disease cells
por: Hart, Hannah S., et al.
Publicado: (2022)

In situ detection of GM1 and GM2 gangliosides using immunohistochemical and immunofluorescent techniques for auxiliary diagnosis of canine and feline gangliosidoses
por: Kohyama, Moeko, et al.
Publicado: (2016)

Subacute Sensorimotor Neuropathy Accompanied by Anti-ganglioside GM1 Antibody in a Patient with Lung Cancer
por: Kanaji, Nobuhiro, et al.
Publicado: (2018)

Anti-ganglioside antibodies induced in chickens by an alum-adsorbed anti-idiotype antibody targeting NeuGcGM3
por: Guthmann, Marcelo D., et al.
Publicado: (2013)

Lyso-GM2 Ganglioside: A Possible Biomarker of Tay-Sachs Disease and Sandhoff Disease
por: Kodama, Takashi, et al.
Publicado: (2011)

GM(1) Ganglioside Inhibits β‐Amyloid Oligomerization Induced by Sphingomyelin
por: Amaro, Mariana, et al.
Publicado: (2016)

Disease‐modifying effects of ganglioside GM1 in Huntington's disease models
por: Alpaugh, Melanie, et al.
Publicado: (2017)

Ganglioside GM1 Targets Astrocytes to Stimulate Cerebral Energy Metabolism
por: Finsterwald, Charles, et al.
Publicado: (2021)

Ganglioside GM3 Synthase Deficiency in Mouse Models and Human Patients
por: Inamori, Kei-ichiro, et al.
Publicado: (2022)

The relationship between depletion of brain GM1 ganglioside and Parkinson's disease
por: Sonnino, Sandro
Publicado: (2023)

Eficacia de los pulsos de corticoides en pacientes con síndrome de liberación de citocinas inducido por infección por SARS-CoV-2
por: Callejas Rubio, José Luis, et al.
Publicado: (2020)

Phase I Study of Anti-GM2 Ganglioside Monoclonal Antibody BIW-8962 as Monotherapy in Patients with Previously Treated Multiple Myeloma
por: Baz, Rachid C., et al.
Publicado: (2016)

Pre-diagnosing and managing patients with GM1 gangliosidosis and related disorders by the evaluation of GM1 ganglioside content
por: Tonin, Rodolfo, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_s6b94d2faa7bto5qh8uq7laeoi